|
|
Biomarkers for Detection and Prediction of Chemotherapy-Related Cognitive Impairment |
| 3P30CA014520-48S5 |
|
NCI |
2022 |
|
|
Hedgehog/GLI1-mediated regulation of DNA repair in cancer, aging and neurodegenerative diseases |
| 3R01CA219187-05S1 |
|
NCI |
2022 |
|
|
Human Endogenous retroviruses as potential early markers for Alzheimers disease |
| 3R01CA226570-04S1 |
|
NCI |
2022 |
|
|
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects |
| 3R01CA248103-02S1 |
|
NCI |
2022 |
|
|
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects |
| 3R01CA248103-02S2 |
|
NCI |
2022 |
|
|
Aging-Related Biomarkers of Neurocognitive Function in Long-term Hodgkin Lymphoma Survivors |
| 4R00CA256356-03 |
|
NCI |
2022 |
|
|
Integrative Molecular Epidemiology of Neurocognitive Outcomes in Acute Lymphoblastic Leukemia |
| 5K07CA218362-05 |
|
NCI |
2022 |
|
|
Aging-Related Biomarkers of Neurocognitive Function in Long-term Hodgkin Lymphoma Survivors |
| 5K99CA256356-02 |
|
NCI |
2022 |
|
|
Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors |
| 5R01CA172145-08 |
|
NCI |
2022 |
|
|
Predicting Long-Term Chemotherapy-Related Cognitive Impairment |
| 5R01CA226080-04 |
|
NCI |
2022 |